HomeLGND • NASDAQ
Ligand Pharmaceuticals Inc
$73.10
After Hours:
$73.10
(0.00%)0.00
Closed: Mar 28, 4:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$71.27
Day range
$71.12 - $73.42
Year range
$49.24 - $94.57
Market cap
1.29B USD
Avg Volume
213.38K
P/E ratio
24.12
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
28.10M-44.22%
Operating expense
24.33M-38.67%
Net income
18.19M204.02%
Net profit margin
64.72286.51%
Earnings per share
1.381.47%
EBITDA
5.56M162.05%
Effective tax rate
-6.38%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
170.31M-19.62%
Total assets
787.22M3.22%
Total liabilities
86.30M-47.75%
Total equity
700.91M
Shares outstanding
17.71M
Price to book
1.79
Return on assets
-1.08%
Return on capital
-1.22%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
18.19M204.02%
Cash from operations
8.06M-84.92%
Cash from investing
-10.28M-41.19%
Cash from financing
5.32M200.32%
Net change in cash
3.10M-92.43%
Free cash flow
-40.12M-235.29%
About
Ligand Pharmaceuticals is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further. The company has been the subject of multiple regulatory investigations, negative shorts-seller reports and class action lawsuits amid allegations of securities fraud. In 2018 its CEO was listed among the top five highest paid CEOs in San Diego. Wikipedia
Founded
Sep 1987
Website
Employees
58
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu